Comparison of Qigong and Otago in Patient With Diabetic Neuropathy

NCT07575126 | Not Yet Recruiting

• 1 other identifier: REC/RCR &AHS/24/0297
• Study Type: interventional
• Target: 44
• Locations: 1 country
• Sites: 1

Brief Summary

This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition

Conditions

Diabetic Neuropathies

Outcome Measures

Primary Outcomes (5)

• Agility T-Test

  The Agility T-Test is a performance-based assessment that measures an individual's agility and ability to change direction quickly. It involves a sequence where the participant runs to a designated point, makes sharp turns around markers in a T-shaped layout, and returns to the starting position.

  12th week

• Berg Balance Scale

  is the gold standard test for static and dynamic balance abilities. The BBS is used to measure ability to maintain balance while doing functional task search as reach, standing position and transferences. It is a valid instrument used for the evaluation of effectiveness of interventions with quantitative description of function in clinical practice as well as research. It consists of 14 items including simple balance tasks from everyday life.

  12th week

• Functional Reach Test

  FRT is a single item test for dynamic balance and acts as a quick screen for balance problems in older adults. The distance between the lengths of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support is measured. A score of 6 inches or less indicates a significant increased risk for falls. A score between 6-10 inches indicates a moderate risk for falls. the Functional Reach Test (FRT) demonstrates an ICC of approximately 0.85 to 0.94

  12th week

• Gait Speed Test

  The Gait Speed Test measures the time it takes for an individual to walk a specific distance, usually 10 meters, at their usual pace. It has demonstrated strong validity and reliability, with an Intra class Correlation Coefficient (ICC) often exceeding 0.90

  12th week

• 10-Meter Walk Test

  The 10-Meter Walk Test involves timing a participant as they walk a distance of 10 meters at their comfortable pace. It assesses gait speed, which is an important indicator of mobility and overall functional ability.

  12th week

Study Arms (2)

Qigong Balance

EXPERIMENTAL

Other: Qigong Balance

Otago Balance

ACTIVE COMPARATOR

Other: Otago Balance

Interventions

Qigong Balance OTHER

Quigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation. Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination. Playing with Water: Slow, flowing movements that enhance balance and mindfulness. Weight Shifting and Balance Exercises: Stand with feet hip-width apart, shifting weight slowly from one leg to the other, holding each position for 10-15 seconds to engage stabilizing muscles in the legs and improve proprioception. Leg Lifts and Extensions: Perform controlled leg lifts (front, side, and back) to strengthen the quadriceps, hamstrings, and hip abductors.

Qigong Balance

Otago Balance OTHER

Otago (Strengthening) Balance: Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability. Balance Training: Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session

Otago Balance

Eligibility Criteria

• Age: 45 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
• Type 2 diabetic peripheral neuropathy patients
• The ability to walk independently for 10 m
• Having score between 46 to 52 (out of a total of 56 points) on the BBS

You may not qualify if:

• Fracture of the lower limb within the 6 months before the study (15)
• Diabetic ulcer, infection or partial amputation in feet (15)
• Disease or functional impairment of auditory, vestibular system (16)
• Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
• Dementia or inability to give consistent information (18)
• History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

DHQ Gujranwala

Guiranwala, Punjab Province, 54500, Pakistan

Location

MeSH Terms

Conditions

Diabetic Neuropathies

Condition Hierarchy (Ancestors)

Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Diabetes Complications; Diabetes Mellitus; Endocrine System Diseases

Study Officials

• Javeria Ghazal, MS

  Riphah International University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Muneeb Khan, PhD

CONTACT

+92336799611; muneeb.khan@riphah.edu.pk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 23, 2026
• First Posted: May 8, 2026
• Study Start (Estimated): May 15, 2026
• Primary Completion (Estimated): August 15, 2026
• Study Completion (Estimated): August 30, 2026
• Last Updated: May 8, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)